AU
BMY icon

AlphaGrep UK’s Bristol-Myers Squibb BMY Stock Holding History

AlphaGrep UK’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Buy
+7,606
New +$437K 0.13% 279
2026
Q1 		– Sell
-13,205
Closed -$712K – 790
2025
Q4 		$712K Buy
+13,205
New +$635K 0.24% 99

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaGrep UK's BMY Position: Q2 2026 in Review

AlphaGrep UK opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 7,606 shares worth $438K. The stake represents 0.13% of the portfolio and ranks #279 among its holdings. This is a return to the name: AlphaGrep UK previously reported a position in BMY as recently as Q4 2025.

AlphaGrep UK first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. The position peaked at $712K in Q4 2025. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • AlphaGrep UK held 7,606 shares of Bristol-Myers Squibb worth $438K as of Q2 2026.
  • Bristol-Myers Squibb was a new AlphaGrep UK position in Q2 2026.
  • Bristol-Myers Squibb made up 0.13% of AlphaGrep UK's portfolio in Q2 2026, its #279 holding.
  • AlphaGrep UK first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
  • AlphaGrep UK's Bristol-Myers Squibb position peaked at $712K in Q4 2025.
  • 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.